Purpose of the Hatch-Waxman Act
|
|
- Emmeline Fields
- 5 years ago
- Views:
Transcription
1
2 Purpose of the Hatch-Waxman Act The purpose of the Act was to make available more low cost generic drugs by establishing a generic drug approval process for pioneer drugs first approved after H.R. Rep. No , Pt. 1, at 14 (June 21, 1984). The Act was legislatively negotiated to strike a balance between two potentially competing policy interests inducing pioneering development of pharmaceutical formulations and methods and facilitating efficient transition to a market with low-cost, generic copies of those pioneering inventions at the close of a patent term. Novo Nordisk A/S, et al. v. Caraco Pharmaceutical Laboratories, Ltd., et al., No (Fed. Cir., April 14, 2010), at 2. 2
3 Basic Structure of the Act I Orange Book Listings by NDA Holder Abbreviated New Drug Applications (ANDA) Bioequivalence vs. Repetitive Clinical Trials Patent Certifications by ANDA Applicants Especially Paragraph IV Certifications Notice Letter to Patent Owner 45-Days for Patent Owner to Sue 30-Month Stay of FDA Approval of ANDA 180-Day Marketing Exclusivity for Successful First-Filer delayed FDA approval of 2d ANDAs 3
4 Basic Structure of the Act II Patent term extension - up to five years to compensate a patent owner for the marketing time allegedly lost in the FDA drug approval process. Total patent term extension of up to 14 years. NDA holder has Data Exclusivity for five years after date of FDA approval of a New Chemical Entity (NCE) NDA holder has Data Exclusivity for three years after date of FDA approval of a new use of an existing and previously approved chemical entity, or new dosage form using that chemical entity. 4
5 Basic Structure of the Act III FDA is not permitted to approve an ANDA that relies upon clinical trials during the NDA holder s Data Exclusivity period. Applicants permitted to file ANDAs one-year prior to expiration of Data Exclusivity period (NCE-1). MMA (2003) provides forfeiture of ANDA First- Filer s 180-day Marketing Exclusivity under certain circumstances. MMA also creates right to file counterclaim seek correction or de-listing of Orange Book patents. 5
6 Where We Are Now: Statistics I In 2008, US national health expenditures totaled $2.33 trillion % of our GDP ($7681 per capita). 6
7 Health expenditure per capita varies widely across OECD countries. US almost 2x OECD average (for insured population). 1. Health expenditure is for the insured population rather than resident population. 2. Current health expenditure. Source: OECD Health Data 2009, OECD ( (last visit 5/5/2010).
8 OECD countries spend about 9% of GDP on health. From 16% in the United States to less than 6% in Turkey. % GDP 20 Public expenditure Private expenditure Turkey Mexico Poland Czech Korea Luxembourg3 Hungary Ireland Slovak Japan Finland United Spain Australia Italy OECD Norway Sweden New Zealand2 Iceland Greece Denmark Netherlands1 Portugal Austria Canada Belgium1 Germany Switzerland France United States 1. Public and private expenditures are current expenditures (excluding investments). 2. Current health expenditure.. 3. Health expenditure is for the insured population rather than resident population. Source: 8 OECD Health Data 2009, OECD ( (last visit 5/5/2010)..
9 Share of GDP spent on health increasing in all OECD countries, mostly due to new medical technologies and population aging. Source: OECD Health Data 2009, OECD (
10 Higher health spending generally associated with higher life expectancy 2007 (or latest year available) Source: OECD Health Data 2009, OECD (
11 Where We Are Now: Statistics II By 2019, US national health care expenditures will be nearly $4.5 trillion % of GDP ($13,387 per capita). 11
12 Where We Are Now: Statistics III From 1980 to 2008, expenditures on prescription drugs rose from $12 billion (4.7% of total health care expenditures) to $234.1 billion (10%). By 2019, prescription drug expenditures are projected to increase to $457.8 billion (10%), an increase from $769 per capita in 2008 to $1,367 per capita in Between January 2000 and December 2004, the price of a one-month supply of the 96 of the most commonly used prescription drugs increased by 24.5%, double that of consumer prices generally. 12
13 Where We Are Now: Statistics IV In the year ending September 2009, the 19 largest pharmaceutical manufacturers (not P&G) reported consolidated revenues of $558 billion, an average of $29.39 billion. These companies had net income of $96 billion, an average of $5.08 billion, or 16.5% of revenues, representing an average return of 16.48% on assets, and 21.23% on shareholder equity. These companies spent $88.9 billion on research and development, an average of $4.681 billion, representing 16.28% of average total revenues. 13
14 14 Congressional Budget Office, Pharmaceutical R&D and the Evolving Market for Prescription Drugs, at 2 (October 2009)
15 Where We Are Now: ANDA Filings Food and Drug Administration, Office of Pharmaceutical Science, Generic Drugs: Overview of ANDA Review Process, UCM pdf 15
16 Where We Are Now: ANDA Approvals Food and Drug Administration, Office of Pharmaceutical Science, Generic Drugs: Overview of ANDA Review Process, UCM pdf 16
17 a96210VgnVCM100000ed152ca2RCRD&vgnextfmt=default
18 3a96210VgnVCM100000ed152ca2RCRD&vgnextfmt=default 18
19 19 DATA EXCLUSIVITY: Should be Left As-Is Grabowski s Chart
20 20 DATA EXCLUSIVITY: Should be Left As-Is Brill s Charts I
21 21 DATA EXCLUSIVITY: Should be Left As-Is Brill s Charts II
22 22 DATA EXCLUSIVITY: Should be Left As-Is Brill s Charts III
23 DATA EXCLUSIVITY: Should be Left As-Is Real-world conclusions about investment behavior, including the behaviors of branded pharmaceutical companies in making investments in research and development of both NCEs and new biological entities (NBEs), can only be seen partially through the lens of these studies. Real-world data strongly suggests that branded companies and their shareholders continue to make substantial investments in research and development, and that they realize significant returns on those investments. Until greater evidence is provided of a need to change, the data exclusivity provided to NCEs in the Hatch-Waxman Act should not be enlarged. 23
24 180-day Exclusivity Should be Rolling I 180-day Marketing Exclusivity created to encourage Paragraph IV challenges by rewarding First Filers for undertaking the costs and risks of patent litigation, to challenge weak or improperly obtained patents, or to defend non-infringing generic products. At one time, very valuable to generic manufacturers, as they can sell product at a price significantly higher than they could if multiple generics were on the market. 24
25 180-day Exclusivity Should be Rolling II Perhaps no single provision of the 1984 law has caused so much controversy as the 180-day marketing exclusivity rule. (Sen. Hatch) Recent MMA Amendments have not solved all problems, have reduced the incentive, and have created new issues. Settlement agreements are still made that have the effect of delaying market competition, even after the MMA, and have continued to raise antitrust concerns. 25
26 180-day Exclusivity Should be Rolling III Branded companies still employ strategies designed to eliminate or diminish the reward for successful First Filers, built into the Act, in the 180-day provision. Litigation over FDA actions affecting 180-day Marketing Exclusivity continues. See, e.g., Teva Pharmaceuticals, Inc. v. Kathleen Sebelius, et al., No (D.C.Cir., March 2, 2010); and Millenium Pharmaceuticals, Inc., et al. v. Teva Parental Medicines, Inc., et al., 2010 WL (D.Del., April 14, 2010). 26
27 180-day Exclusivity Should be Rolling III The Act should be amended to provide 180-day exclusivity to a second, successful ANDA applicant, in the event the NDA holder settles with the First-Filer and the First Filer does not enter the market within 180 days after such settlement. 27
28 Orange Book Delisting Provisions Should be Strengthened I In Teva, the D.C. Court of Appeals ruled that Teva had standing to challenge a patent de-listing, broadly applying the purposes of the Act. Teva commented:...letting brand makers delist challenged patents in order to trigger a forfeiture of exclusivity would be completely ineffective; given the incentives for the brand manufacturer, it will be used only where its impact on Congress s scheme is most destructive.... If the generic appears unlikely to park its exclusivity, the brand maker can delist well before the generic can go to market, thus eviscerating the exclusivity incentive altogether. Teva held that the FDA may not de-list an Orange Book patent, if, after serving a Paragraph IV notice with respect to one of three Orange Book patents, the NDA Holder asks that the challenged patent be withdrawn from the Orange Book. 28
29 Orange Book Delisting Provisions Should be Strengthened II The Federal Circuit ruled, in Novo Nordisk A/S, et al. v. Caraco Pharmaceutical Laboratories, Ltd., et al., No (Fed. Cir., April 14, 2010), that the Hatch-Waxman Act authorizes a counterclaim only if the listed patent does not claim any approved methods of using the listed drug. Novo Nordisk involved a change by the NDA Holder in the use code narrative that expanded the use description for the product, Prandin, a change that caused the FDA to deny Caraco s carve out, based upon the original use code. Caraco, the generic manufacturer, counterclaimed under MMA provisions, to challenge the change in use code. The Federal Circuit reversed the trial court s grant of summary judgment on this de-listing issue, and its grant of an injunction requiring Novo Nordisk to reinstate the prior use code. 29
30 Orange Book Delisting Provisions Should be Strengthened III The counterclaim provision of was added in the MMA, in order to prevent manipulative practices by patent holders with respect to the Orange Book listings, that were designed to delay the onset of competition from generic drug manufacturers. Strict construction of the MMA counterclaim provision lead to the decision in Novo Nordisk, a result that defeats the purpose of the MMA amendments. Purposive construction, like that used in Teva, has lead to other results or conclusions that may not be entirely satisfactory. The Act should be amended to clearly provide for US District Court jurisdiction over declaratory judgment actions brought by ANDA applicants to review the propriety of any listing related to any patent in the Orange Book. 30
31 Standards for Measuring Intent Should be Uniform I Exergen Corp. v. Wal-Mart Stores, Inc., 573 F.3d 1312 (2009) applied FRCP Rule 9(b) and 37 C.F.R. 1.56, and held that to plead the circumstances of inequitable conduct with the requisite particularity a pleading must identify the specific who, what, when, where, and how of the material misrepresentation before the PTO. In SEB., S.A. v. T-Fal Corporation, the Federal Circuit determined that induced infringement may be proven by a showing of deliberate indifference to the existence of a patent. The CAFC recently granted en banc review in Therasense, Inc. v. Becton Dickinson and Co., No o (April 26, 2010), to consider standards for assessing materiality in inequitable conduct cases, and whether the standards should be tied directly to fraud or unclean hands. 31
32 Standards for Measuring Intent Should be Uniform II The most recent drafts of the Patent Reform Act of 2009, especially the Manager s Amendment, omit previously suggested provisions relating to inequitable conduct, that were motivated by the perceived failure of the Federal Circuit to establish one clear standard of materiality for inequitable conduct purposes.. The absence of clear standards for assessment of intent has lead or may lead to confusing and inconsistent results. There is no valid reason for applying different standards of intent in Hatch-Waxman cases involving different portions of Patent Act, or applying a PTO regulation based on the Act generally, when none of those provisions contain any legislative standard. Instead, a single standard should apply. 32
33 Standards for Measuring Intent Should be Uniform III The Hatch-Waxman Act should be amended to provide that, in cases arising under the Act, where no other standard is provided in the Patent Act, the level of intent that should be required is willfulness, as that term has been and may be applied in the courts, generally. The Hatch-Waxman Act should be amended to provide a clear statutory basis for the doctrine of inequitable conduct that, in cases arising under the Act, should be applied based upon a showing of knowing statements or omissions of material information which were or had the effect of misleading the USPTO. Liability for such inequitable conduct, in the view of the author, should not be limited, in Hatch-Waxman cases, to individuals involved in the prosecution of a patent, but should extend to corporate knowledge, as in cases of fraud under other statutes that prohibit false statements to the Federal government. 33
34 Authorized Generics Should be Abolished I Authorized generics contravene the purposes of the Hatch-Waxman legislatively supervised, negotiated compromise. They disrupt the bounty system established by the Hatch-Waxman Act. The loophole in the Hatch-Waxman scheme that permits introduction of authorized generics during the 180-day exclusivity period, diverts a significant portion of sales that would be realized by a successful generic challenger to the authorized generic and its branded sponsor. Authorized generics negatively affect the incentive given to generic manufactures to challenge drug patents. 34
35 Authorized Generics Should be Abolished II Authorized generics may help consumers by lowering short-term prices. Authorized generics should be banned as a strategic response to impending Paragraph IV entry, but should be allowed in their absence or after 180-day exclusivity expiration. The Hatch-Waxman Act should be amended to prohibit the introduction of an authorized generic equivalent to a branded product, either directly or indirectly, by an NDA holder, during the 180-day Hatch-Waxman exclusivity period. 35
36
Corrigendum. OECD Pensions Outlook 2012 DOI: ISBN (print) ISBN (PDF) OECD 2012
OECD Pensions Outlook 2012 DOI: http://dx.doi.org/9789264169401-en ISBN 978-92-64-16939-5 (print) ISBN 978-92-64-16940-1 (PDF) OECD 2012 Corrigendum Page 21: Figure 1.1. Average annual real net investment
More information8-Jun-06 Personal Income Top Marginal Tax Rate,
8-Jun-06 Personal Income Top Marginal Tax Rate, 1975-2005 2005 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 Australia 47% 47% 47% 47% 47% 47% 47% 47% 47% 47% 47% 48% 49% 49% Austria
More informationHousehold Financial Wealth By Selected Country
Household Financial Wealth By Selected Country US$ Trillions 60 50-37% Indicates Projected Shortfall 40 30 20 Extrapolation of Historical Growth 2003-24 Projection (Based on Demographic Trends) -47% -34%
More informationGatifloxacin for Enteric Fever
This document contains information on the patent status for gatifloxacin from two sources: 1. Dae Oh. Drugs in Focus: Gatifloxacin http://www.genericsweb.com/index.php?object_id=807 (downloaded on 10Nov2010)
More informationBurden of Taxation: International Comparisons
Burden of Taxation: International Comparisons Standard Note: SN/EP/3235 Last updated: 15 October 2008 Author: Bryn Morgan Economic Policy & Statistics Section This note presents data comparing the national
More informationSources of Government Revenue in the OECD, 2016
FISCAL FACT No. 517 July, 2016 Sources of Government Revenue in the OECD, 2016 By Kyle Pomerleau Director of Federal Projects Kevin Adams Research Assistant Key Findings OECD countries rely heavily on
More informationApproach to Employment Injury (EI) compensation benefits in the EU and OECD
Approach to (EI) compensation benefits in the EU and OECD The benefits of protection can be divided in three main groups. The cash benefits include disability pensions, survivor's pensions and other short-
More informationPerformance Budgeting (PB) in OECD Countries
Performance Budgeting (PB) in OECD Countries Teresa Curristine, Budgeting and Public Expenditures Division, Public Governance Directorate, OECD 6 th Annual Meeting of Latin American Senior Budget Officials
More informationStatistical annex. Sources and definitions
Statistical annex Sources and definitions Most of the statistics shown in these tables can be found as well in several other (paper or electronic) publications or references, as follows: the annual edition
More informationHealth Care in Crisis
Health Care in Crisis The Economic Imperative for Health Care Reform James Kvaal and Ben Furnas February 19, 2009 1 Center for American Progress Health Care in Crisis U.S. spends twice as much per capita
More informationPENSIONS IN OECD COUNTRIES: INDICATORS AND DEVELOPMENTS
PENSIONS IN OECD COUNTRIES: INDICATORS AND DEVELOPMENTS Marius Lüske Directorate for Employment, Labour and Social Affairs, OECD Lisbon, 28.09.2018 Marius.LUSKE@oecd.org www.oecd.org/els OUTLINE Talk based
More informationUS Reimbursement Systems: Effects on R&D
US Reimbursement Systems: Effects on R&D Patricia M. Danzon, PhD Professor Emeritus The Wharton School University of Pennsylvania Theory: Optimal Reimbursement Rules to Create Efficient R&D Incentives
More informationThe Case for Fundamental Tax Reform: Overview of the Current Tax System
The Case for Fundamental Tax Reform: Overview of the Current Tax System Sources of Federal Receipts Projected for 2016 Excise Taxes 2.9% Estate & Gift Taxes 0.6% Corporate Income Taxes 9.8% Other Taxes
More informationAmerican healthcare: How do we measure up?
American healthcare: How do we measure up? December 2009 September 2009 Lauren Damme Economic Growth Program Next Social Contract Initiative The U.S. is one of the only industrialized nations in the world
More informationInvestment in Health is investment in wealth: the positive dimension of healthcare K. Panagoulias, Al.President SFEE
Investment in Health is investment in wealth: the positive dimension of healthcare K. Panagoulias, Al.President SFEE Healthworld Conference, October 2017 % Healthcare as % of GDP 14,00% 12,00% 10,00% 11,0%
More informationAmerican healthcare: How do we measure up?
American healthcare: How do we measure up? December 2009 September 2009 Lauren Damme Economic Growth Program Next Social Contract Initiative The U.S. is one of the only industrialized nations in the world
More informationAgeing and employment policies: Ireland
Ageing and employment policies: Ireland John Martin 1 Director for Employment, Labour and Social Affairs, OECD FÁS Annual Labour Market Conference, Dublin, 5 December 2005 OECD has carried out a major
More informationLow employment among the 50+ population in Hungary
Low employment among the + population in Hungary The role of incentives, health and cognitive capacities Janos Divenyi (Central European University) and Gabor Kezdi (Central European University and IE-CRSHAS)
More informationOECD HEALTH SYSTEM CHARACTERISTICS SURVEY 2012
OECD HEALTH SYSTEM CHARACTERISTICS SURVEY 2012 Emily Hewlett OECD Health Data National Correspondents and Health Accounts Experts Meeting, 17 th October 2013 Health System Characteristics Survey 2012 HSC
More informationOECD Report Shows Tax Burdens Falling in Many OECD Countries
OECD Centres Germany Berlin (49-30) 288 8353 Japan Tokyo (81-3) 5532-0021 Mexico Mexico (52-55) 5281 3810 United States Washington (1-202) 785 6323 AUSTRALIA AUSTRIA BELGIUM CANADA CZECH REPUBLIC DENMARK
More informationTAX POLICY CENTER BRIEFING BOOK. Background. Q. What are the sources of revenue for the federal government?
What are the sources of revenue for the federal government? FEDERAL BUDGET 1/4 Q. What are the sources of revenue for the federal government? A. About 48 percent of federal revenue comes from individual
More informationAgreements Filed with the Federal Trade Commission under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003
Agreements Filed with the Federal Trade Commission under the Medicare Prescription Drug, Improvement, and Modernization Act of 003 Summary of Agreements Filed in FY 007 A Report by the Bureau of Competition
More informationCOVERAGE OF PRIVATE PENSION SYSTEMS AND MAIN TRENDS IN THE PENSIONS INDUSTRY IN THE OECD
COVERAGE OF PRIVATE PENSION SYSTEMS AND MAIN TRENDS IN THE PENSIONS INDUSTRY IN THE OECD Fafo Pension Forum Oslo, 16 November 2012 Stéphanie Payet OECD Financial Affairs Division Structure of the Presentation
More informationBehaviour in Business A Guide to Integrity in Business Transactions
Behaviour in Business A Guide to Integrity in Business Transactions Contents I Preamble 4 Business Integrity 5 II 1.1 Objectives and Topics 5 1.2 Definition of Business Integrity 5 1.3 Responsibility
More informationDouble-Taxing Capital Income: How Bad Is the Problem?
November 15, 2006 Double-Taxing Capital Income: How Bad Is the Problem? by Patrick Fleenor Fiscal Fact No. 71 Introduction Double taxation is a common and often misused expression in tax policy discussions.
More informationSources of Government Revenue in the OECD, 2017
FISCAL FACT No. 558 Aug. 2017 Sources of Government Revenue in the OECD, 2017 Amir El-Sibaie Analyst Key Findings: OECD countries rely heavily on consumption taxes, such as the value-added tax, and social
More informationSources of Government Revenue in the OECD, 2018
FISCAL FACT No. 581 Mar. 2018 Sources of Government Revenue in the OECD, 2018 Amir El-Sibaie Analyst Key Findings In 2015, OECD countries relied heavily on consumption taxes, such as the value-added tax,
More informationImproving data on pharmaceuticals. Meeting of OECD Health Data National Correspondents 3-4 october 2011
Improving data on pharmaceuticals Meeting of OECD Health Data National Correspondents 3-4 october 2011 Purpose of this agenda item Present the current content of OECD health data on pharmaceuticals Propose
More informationHEALTH LABOUR MARKET TRENDS IN OECD COUNTRIES
HEALTH LABOUR MARKET TRENDS IN OECD COUNTRIES Michael Schoenstein, OECD Health Division 3 rd Global Health Workforce Alliance Forum Recife, 11 November 2013 Main health labour market issues in OECD countries
More informationSources of Government Revenue in the OECD, 2014
FISCAL FACT Nov. 2014 No. 443 Sources of Government Revenue in the OECD, 2014 By Kyle Pomerleau Economist Key Findings OECD countries rely heavily on consumption taxes, such as the value added tax, and
More informationNuts & Bolts of Corporate Tax Reform
Nuts & Bolts of Corporate Tax Reform July 19, 2013 Presentation for the Alliance for a Just Society Steve Wamhoff, Citizens for Tax Justice The Work of Citizens for Tax Justice (CTJ) on Federal Tax Policy
More informationGlossary of Defined Terms
Glossary of Defined Terms Glossary History Change Date April 2007 July 2007 Description of Changes Initial Launch Amendment of definition of administrator(s) Glossary History July 2007 Page 1 of 1 A Accredited
More informationSwitzerland and Germany top the PwC Young Workers Index in developing younger people
Press release Date 9 November 2015 Contact Mihnea Anastasiu Pages 5 Media Relations Manager Tel: +40 21 225 3546 Email: mihnea.anastasiu@ro.pwc.com Switzerland and Germany top the PwC Young Workers Index
More informationGrowth in OECD Unit Labour Costs slows to 0.4% in the third quarter of 2016
Growth in OECD Unit Labour Costs slows to.4% in the third quarter of 26 Growth in unit labour costs (ULCs) in the OECD area slowed to.4% in the third quarter of 26 (compared with.6% in the previous quarter)
More informationEFFECTIVE DATE November 1, ISSUED BY: Compliance and Legal Department APPROVED BY: Board of Directors
Valeant Pharmaceuticals International, Inc. POLICY NO. H.R. Sec. 9 914 EFFECTIVE DATE November 1, 2013 PAGE NO. 1 of 9 SUBJECT: ISSUED BY: Compliance and Legal Department APPROVED BY: Board of Directors
More informationCOMPARISON OF RIA SYSTEMS IN OECD COUNTRIES
COMPARISON OF RIA SYSTEMS IN OECD COUNTRIES Nick Malyshev, OECD Conference on the Further Development of Impact Assessment in the European Union Brussels, RIA SYSTEMS IN OECD COUNTRIES Regulatory Impact
More informationAn Overview of the Foreign Corrupt Practices Act
BEIJING BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG LONDON LOS ANGELES NEW YORK SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.C. An Overview of the Foreign Corrupt Practices Act Presentation
More informationEFFECTIVE DATE August 17, ISSUED BY: Compliance and Legal Department APPROVED BY: Board of Directors
Valeant Pharmaceuticals International, Inc. POLICY NO. H.R. Sec. 9 914 EFFECTIVE DATE August 17, 2016 PAGE NO. 1 of 9 SUBJECT: ISSUED BY: Compliance and Legal Department APPROVED BY: Board of Directors
More informationTAXATION OF TRUSTS IN ISRAEL. An Opportunity For Foreign Residents. Dr. Avi Nov
TAXATION OF TRUSTS IN ISRAEL An Opportunity For Foreign Residents Dr. Avi Nov Short Bio Dr. Avi Nov is an Israeli lawyer who represents taxpayers, individuals and entities. Areas of Practice: Tax Law,
More informationReporting practices for domestic and total debt securities
Last updated: 27 November 2017 Reporting practices for domestic and total debt securities While the BIS debt securities statistics are in principle harmonised with the recommendations in the Handbook on
More information2018 INTERNATIONAL CONFERENCE ON MUNICIPAL FISCAL HEALTH U.S. Tax Reform and Its Impact on State and Local Government Finance Presented by Jane L.
2018 INTERNATIONAL CONFERENCE ON MUNICIPAL FISCAL HEALTH U.S. Tax Reform and Its Impact on State and Local Government Finance Presented by Jane L. Campbell ; Director NDC Washington Office National Development
More information10% 10% 15% 15% Caseload: WE. 15% Caseload: SS 10% 10% 15%
Percentchangeincaseload 15% 10% 5% 0% 5% 10% 15% Caseload: AO 0 1 2 3 4 5 Percentchangein caseload 15% 10% 5% 0% 5% 10% 15% Caseload: NC 0 1 2 3 4 5 Years Years Percentchangein caseload 15% 10% 5% 0% 5%
More informationPublic Financial Management (PFMx) Module
Public Financial Management (PFMx) Module 4 The Annual Budget Preparation and Approval This training material is the property of the International Monetary Fund (IMF) and is intended for use in IMF Fiscal
More informationStatistical Annex ANNEX
ISBN 92-64-02384-4 OECD Employment Outlook Boosting Jobs and Incomes OECD 2006 ANNEX Statistical Annex Sources and definitions Most of the statistics shown in these tables can be found as well in three
More informationGuidance on Transfer Pricing Documentation and Country-by-Country Reporting
OECD/G20 Base Erosion and Profit Shifting Project Guidance on Transfer Pricing Documentation and Country-by-Country Reporting ACTION 13: 2014 Deliverable ANNEX II TO CHAPTER V. TRANSFER PRICING DOCUMENTATION
More informationSources of Government Revenue across the OECD, 2015
FISCAL FACT Apr. 2015 No. 465 Sources of Government Revenue across the OECD, 2015 By Kyle Pomerleau Economist Key Findings OECD countries rely heavily on consumption taxes, such as the value added tax,
More informationGross Domestic Expenditures on Research and Development in Canada (GERD), and the Provinces
Catalogue no. 88-221-X Gross Domestic Expenditures on Research and Development in Canada (GERD), and the Provinces National estimates 2002 to 2012 / estimates 2006 to 2010 How to obtain more information
More informationTurkey s Saving Deficit Issue From an Institutional Perspective
Turkey s Saving Deficit Issue From an Institutional Perspective Engin KURUN, Ph.D CEO, Ziraat Asset Management Oct. 25th, 2011 - Istanbul 1 PRESENTATION Household and Institutional Savings Institutional
More informationLA COPERTURA DEI SERVIZI SANITARI NEI PAESI OCSE. Annalisa Belloni
LA COPERTURA DEI SERVIZI SANITARI NEI PAESI OCSE Annalisa Belloni Agenda Com è organizzata la copertura sanitaria? Come misurarla? Quali cambiamenti e quale impatto? Il ruolo dell HTA Three Dimensions
More informationRecommendation of the Council concerning Consumer Protection in the Field of Consumer Credit
Recommendation of the Council concerning Consumer Protection in the Field of Consumer Credit OECD Legal Instruments This document is published under the responsibility of the Secretary-General of the OECD.
More informationBudget repair and the size of Australia s government. Melbourne Economic Forum John Daley, Grattan Institute December 2015
Budget repair and the size of Australia s government Melbourne Economic Forum John Daley, Grattan Institute December 2015 Budget repair and the size of Australia s government Attitudes to the best approach
More informationWorking Group on Bribery: 2012 Data on Enforcement of the Anti-Bribery Convention
Working Group on Bribery: 2012 Data on Enforcement of the Anti-Bribery Convention Highlights from the Working Group on Bribery Enforcement Data, as of December 2012 221 individuals and 90 entities have
More informationRecommendation of the Council on Tax Avoidance and Evasion
Recommendation of the Council on Tax Avoidance and Evasion OECD Legal Instruments This document is published under the responsibility of the Secretary-General of the OECD. It reproduces an OECD Legal Instrument
More informationFCCC/SBI/2010/10/Add.1
United Nations Framework Convention on Climate Change Distr.: General 25 August 2010 Original: English Subsidiary Body for Implementation Contents Report of the Subsidiary Body for Implementation on its
More informationCANADA S LABOUR MARKET PRE- AND POST-CRISIS
CANADA S LABOUR MARKET PRE- AND POST-CRISIS WILLIAM ROBSON PRESIDENT AND CEO, C.D. HOWE INSTITUTE PRESENTATION TO THE NERO MEETING AT THE OECD 20 JUNE 2011 CANADA S LABOUR MARKET HIGHLIGHTS Decent Top-Level
More informationBudget repair and the changing size of Australia s government. Crawford Australian Leadership Forum John Daley, Grattan Institute June 2016
Budget repair and the changing size of Australia s government Crawford Australian Leadership Forum John Daley, Grattan Institute June 2016 Commonwealth expenditure is high relative to history; revenue
More informationEUR billions (b.kr.) 2000 Q3/2008 Q3/
6 This chapter presents Iceland s international investment position, both gross (IIP) and net (NIIP). It discusses pre-crisis debt accumulation and post-crisis developments, describes changes in foreign
More informationFEES SCHEDULE (COPPER / GOLD)
FEES SCHEDULE (COPPER / GOLD) Applicable from April 208 excluding discretionary management agreement and investment advisory agreement CBP Quilvest LU EN Fees Schedule Excluding Management April 208 /5
More informationBETTER POLICIES FOR A SUCCESSFUL TRANSITION TO A LOW-CARBON ECONOMY
BETTER POLICIES FOR A SUCCESSFUL TRANSITION TO A LOW-CARBON ECONOMY Rintaro Tamaki Deputy Secretary-General, OECD International Forum for Sustainable Asia and the Pacific (ISAP)1 Yokohama, July 1 Four
More informationInvesting for our Future Welfare. Peter Whiteford, ANU
Investing for our Future Welfare Peter Whiteford, ANU Investing for our future welfare Presentation to Jobs Australia National Conference, Canberra, 20 October 2016 Peter Whiteford, Crawford School of
More informationALI-ABA Course of Study International Trust and Estate Planning. August 16-17, 2007 Chicago, Illinois
35 ALI-ABA Course of Study International Trust and Estate Planning August 16-17, 2007 Chicago, Illinois Basic U.S. Transfer and Income Tax Rules Applicable to Non-Resident Aliens By Virginia F. Coleman
More informationFiscal Projections in OECD Countries: What is produced and what lessons can be learned?
Fiscal Projections in OECD Countries: What is produced and what lessons can be learned? James Sheppard Policy Analyst, Public Governance and Territorial Development Directorate Joint OECD-IPSASB Seminar
More informationAnnuities: a private solution to longevity risk
Annuities: a private solution to longevity risk Product & Knowledge Fair 2007 Rüschlikon 30 March 2007 Thomas Hess Head of Economic Research & Consulting Veronica Scotti Client Solutions Need for private
More informationInternational Statistical Release
International Statistical Release This release and additional tables of international statistics are available on efama s website (www.efama.org). Worldwide Investment Fund Assets and Flows Trends in the
More informationFEES SCHEDULE (SILVER/PLATINUM)
FEES SCHEDULE (SILVER/PLATINUM) Applicable from April 208 under an Investment Advisory Agreement CBP Quilvest LU EN Investment Advisory Fees Schedule April 208 /5 ADVISORY MANAGEMENT, CUSTODY FEES AND
More informationPolitical Developments & The 2017 Tax Cut and Jobs Act
Political Developments & The 2017 Tax Cut and Jobs Act Moderator Elizabeth Creager, AT&T Assistant Vice President for Tax Panelists Rohit Kumar, PwC Principal & Tax Policy Services Leader Jon Lieber, PwC
More informationThe OECD s Society at a Glance Simon Chapple OECD ELS/SPD Villa Vigoni, Italy, 9-11 th March 2011
The OECD s Society at a Glance 2 Simon Chapple OECD ELS/SPD Villa Vigoni, Italy, 9- th March 2 Reconceptualisation for 2: Internal reasons OECD growth from 3 to 34 countries Other major economies (e.g.
More informationOECD Health Policy Unit. 10 June, 2001
The State of Implementation of the OECD Manual: A System of Health Accounts (SHA) in OECD Member Countries, 2001 OECD Health Policy Unit 10 June, 2001 TABLE OF CONTENTS Summary...3 Introduction...4 Background
More informationPension Fund Investment and Regulation - An International Perspective and Implications for China s Pension System
Pension Fund Investment and Regulation - An International Perspective and Implications for China s Pension System Yu-Wei Hu, Fiona Stewart and Juan Yermo Financial Affairs Division OECD, Paris OECD/IOPS
More informationWays to increase employment
Ways to increase employment Iceland Luxembourg Spain Canada Italy Norway Denmark Germany Portugal Ireland Japan Belgium Switzerland Austria Slovenia United States New Zealand Finland France Netherlands
More informationFinancial Implications of an Ageing Population
Financial Implications of an Ageing Population Presentation to Aged & Community Care Victoria s State Congress and Trade Exhibition Saul Eslake Chief Economist ANZ Flemington Racecourse Melbourne 25 th
More informationStatistical Annex. Sources and definitions
Statistical Annex Sources and definitions Most of the statistics shown in these tables can also be found in two other (paper or electronic) publication and data repository, as follows: The annual edition
More informationPriorities for Productivity and Income (PPIs) Country Results
Priorities for Productivity and Income (PPIs) Country Results Bolivia Alejandro Izquierdo Jimena Llopis Umberto Muratori Jose Juan Ruiz 2015 Priorities for Productivity and Income (PPIs) Country Results
More informationInternational Statistical Release
International Statistical Release This release and additional tables of international statistics are available on efama s website (www.efama.org). Worldwide Investment Fund Assets and Flows Trends in the
More information1 People in Paid Work
1 People in Paid Work Indicator 1.1a Indicator 1.1b Indicator 1.2a Indicator 1.2b Indicator 1.3 Indicator 1.4 Indicator 1.5a Indicator 1.5b Indicator 1.6 Employment and Unemployment Trends (Republic of
More informationInternational Business Transactions. FCPA, OECD Convention and OECD Member States New Legislation
International Business Transactions Introduction to the International Anti-bribery Laws FCPA, OECD Convention and OECD Member States New Legislation Analysis, Comparison and Risk Management A European
More informationIDA13. Further Options for IDA13 Grant Financing
IDA13 Further Options for IDA13 Grant Financing International Development Association January 2004 1. During the IDA13 Mid-Term Review discussions on November 4-5, 2003, Deputies considered several approaches
More informationThe Outlook for the U.S. Economy and the Policies of the New President
The Outlook for the U.S. Economy and the Policies of the New President Jason Furman Senior Fellow, PIIE SNS/SHOF Finance Panel Stockholm June 12, 2017 Peterson Institute for International Economics 1750
More informationInternational Statistical Release
International Statistical Release This release and additional tables of international statistics are available on efama s website (www.efama.org) Worldwide Investment Fund Assets and Flows Trends in the
More informationRecommendation of the Council on the Implementation of the Polluter-Pays Principle
Recommendation of the Council on the Implementation of the Polluter-Pays Principle OECD Legal Instruments This document is published under the responsibility of the Secretary-General of the OECD. It reproduces
More informationImplications of Increases in Life Expectancy for Policy
Implications of Increases in Life Expectancy for Policy By Hilary Waldron, Social Security Administration Adapted from Waldron (2007), Trends in Mortality Differentials and Life Expectancy for Male Social
More informationLinking Education for Eurostat- OECD Countries to Other ICP Regions
International Comparison Program [05.01] Linking Education for Eurostat- OECD Countries to Other ICP Regions Francette Koechlin and Paulus Konijn 8 th Technical Advisory Group Meeting May 20-21, 2013 Washington
More informationCoordinating Central and Local Governments Policy in Iceland. Björn Rúnar Guðmundsson Head of Economic Department Ministry of Economic Affairs
Coordinating Central and Local Governments Policy in Iceland Björn Rúnar Guðmundsson Head of Economic Department Ministry of Economic Affairs A bird s eye view: Municipalities in Iceland Overall number
More information- 7 - INSTRUCTIONS FOR PART 2, CALCULATION OF RISK WEIGHTED ASSETS
- 7 - INSTRUCTIONS FOR PART 2, CALCULATION OF RISK WEIGHTED ASSETS General instructions have been provided below for each row of the worksheet to assist banks in allocating the balance sheet or credit
More informationIndicator B3 How much public and private investment in education is there?
Education at a Glance 2014 OECD indicators 2014 Education at a Glance 2014: OECD Indicators For more information on Education at a Glance 2014 and to access the full set of Indicators, visit www.oecd.org/edu/eag.htm.
More informationSocial Expenditure in Japan: Trends and Backgrounds
Social Expenditure in Japan: Trends and Backgrounds Junko Takezawa The 9th Social Experts Meeting the Center Mark Hotel in Seoul (28 29 October 2014) Presentation Outline 1. Trends in Social Expenditure
More informationDeadlines to preserve taxpayer rights to request competent authority assistance to relieve double taxation
Arm s Length Standard Global views within reach. Deadlines to preserve taxpayer rights to request competent authority assistance to relieve double taxation Transfer pricing continues to be the top enforcement
More informationAvoiding Fraud and Corrupt Practices. Michael Steinberg IES Abroad AIEA Conference February 2014
Avoiding Fraud and Corrupt Practices Michael Steinberg IES Abroad AIEA Conference February 2014 Types of Corruption Bribery Bribery» E Extortion Embezzlement Grey Market Avoiding Fraud and Corrupt practices
More informationEU-28 RECOVERED PAPER STATISTICS. Mr. Giampiero MAGNAGHI On behalf of EuRIC
EU-28 RECOVERED PAPER STATISTICS Mr. Giampiero MAGNAGHI On behalf of EuRIC CONTENTS EU-28 Paper and Board: Consumption and Production EU-28 Recovered Paper: Effective Consumption and Collection EU-28 -
More informationTAX POLICY: RECENT TRENDS AND REFORMS IN OECD COUNTRIES FOREWORD
TAX POLICY: RECENT TRENDS AND REFORMS IN OECD COUNTRIES FOREWORD This publication provides an overview of recent trends in domestic taxation in OECD countries over the period 1999 to 2002, and a summary
More informationPatents and the Polymorph
Patents and the Polymorph Washington, DC (Henry Stuart publ., Feb. 2004) Pharmaceutical Patent Attys, LLC 1 Economic Importance Revenue loss to innovator firms: $51,508,000,000 Revenue gain to generic
More informationLONG-TERM PROJECTIONS OF PUBLIC PENSION EXPENDITURE
7. FINANCES OF RETIREMENT-INCOME SYSTEMS LONG-TERM PROJECTIONS OF PUBLIC PENSION EXPENDITURE Key results Public spending on pensions has been on the rise in most OECD countries for the past decades, as
More informationTable 1: Foreign exchange turnover: Summary of surveys Billions of U.S. dollars. Number of business days
Table 1: Foreign exchange turnover: Summary of surveys Billions of U.S. dollars Total turnover Number of business days Average daily turnover change 1983 103.2 20 5.2 1986 191.2 20 9.6 84.6 1989 299.9
More informationOutlook Overview: OECD Countries UN LINK Conference, Bangkok October, 2009
Outlook Overview: OECD Countries UN LINK Conference, Bangkok 26 28 October, 2009 Dave Turner OECD, Economics Department OECD Outlook: Outline 1. Recovery underway but will probably be slow 2. Risks and
More informationThe Rule of Law as a Factor for Competitiveness
The Rule of Law as a Factor for Competitiveness Lessons from the Global Competitiveness Index 2008-2009 Irene Mia Director, Senior Economist Global Competitiveness Network, World Economic Forum OECD Workshop
More informationNOTE. for the Interparliamentary Meeting of the Committee on Budgets
NOTE for the Interparliamentary Meeting of the Committee on Budgets THE ROLE OF THE EU BUDGET TO SUPPORT MEMBER STATES IN ACHIEVING THEIR ECONOMIC OBJECTIVES AS AGREED WITHIN THE FRAMEWORK OF THE EUROPEAN
More informationThird Revised Decision of the Council concerning National Treatment
Third Revised Decision of the Council concerning National Treatment OECD Legal Instruments This document is published under the responsibility of the Secretary-General of the OECD. It reproduces an OECD
More informationOECD HEALTH DATA 2012 DISSEMINATION AND RESULTS. Marie-Clémence Canaud OECD Health Data National Correspondents Meeting October 12, 2012
OECD HEALTH DATA 2012 DISSEMINATION AND RESULTS Marie-Clémence Canaud OECD Health Data National Correspondents Meeting October 12, 2012 Release of OECD Health Data 2012 Released as planned, June 28 Dissemination
More informationOpen Day 2017 Clearstream execution-to-custody integration Valentin Nehls / Jan Willems. 5 October 2017
Open Day 2017 Clearstream execution-to-custody integration Valentin Nehls / Jan Willems 5 October 2017 Deutsche Börse Group 1 Settlement services: single point of access to cost-effective, low risk and
More informationPlanning for Retirement with Reasonable Targets FCAC-OECD Conference on Financial Literacy
Planning for Retirement with Reasonable Targets FCAC-OECD Conference on Financial Literacy Jack M. Mintz Palmer Chair of Public Policy School of Public Policy The University of Calgary What is the Problem?
More information